Sector Watch: Healthcare - May 10 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $103.73 -0.06 -0.06% | XBI: $89.04 -0.76 -0.85% | Updated May 10, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| ARMO ARMO Biosciences $1.5B |
49.80+19.98 5.3 M 20.0x |
67% | ||
| PBH Prestige Brand Holdings $1.9B |
35.25+6.74 4.5 M 5.8x |
24% | ||
| DEPO Depomed $475.5M |
7.34+1.38 6.1 M 5.2x |
23% | ||
| JNP Juniper Pharmaceuticals $108.3M |
9.75+1.65 194.8 K 2.2x |
20% | ||
| VTVT VTv Therapeutics $67.4M |
2.03+0.32 10.5 M 3.6x |
19% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| AMPH52WL Amphastar Pharmaceuticals $674.1M |
14.63-4.80 1.2 M 10.4x |
-25% | ||
| EYPT Eyepoint Pharmaceuticals $82.7M |
2.00-0.55 2.3 M 1.9x |
-22% | ||
| PBYI Puma Biotechnology Inc $1.9B |
51.80-13.50 5.5 M 10.2x |
-21% | ||
| QHC Quorum Health $178.3M |
6.20-1.23 2.0 M 4.1x |
-17% | ||
| EXEL Exelixis $5.5B |
18.56-3.13 13.6 M 3.8x |
-14% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Depomed Announces First-Quarter 2018 Financial Results [globenewswire.com]ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ARMO BioSciences, Inc. [prnewswire.com]
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018 [globenewswire.com]
Prestige Brands Holdings, Inc. Reports Fiscal 2018 Fourth Quarter and Full Year Results; Provides Fiscal 2019 Outlook [globenewswire.com]
ARMO BioSciences Alert: Johnson Fistel Investigates Proposed Sale of ARMO BioSciences, Inc.; Is $50 [prnewswire.com]
ARMO BioSciences Alert: Johnson Fistel Investigates Proposed Sale of ARMO BioSciences, Inc.; Is $50 a Fair Price? [prnewswire.com]
Lilly Announces Agreement To Acquire ARMO BioSciences [prnewswire.com]
Exelixis Provides Update on IMblaze370 Phase 3 Pivotal Trial of Atezolizumab and Cobimetinib in Patients With Heavily Pretreated Locally Advanced or Metastatic Colorectal Cancer | Business Wire [businesswire.com]
Genentech Provides Update on Phase III Study of TECENTRIQ (Atezolizumab) and COTELLIC (Cobimetinib) in People With Heavily Pre-Treated Locally Advanced or Metastatic Colorectal Cancer | Business Wire [businesswire.com]
Exelixis Provides Update on IMblaze370 Phase 3 Pivotal Trial of Atezolizumab and Cobimetinib in Patients With Heavily Pretreated Locally Advanced or Metastatic Colorectal Cancer [businesswire.com]
Genentech Provides Update on Phase III Study of TECENTRIQ (Atezolizumab) and COTELLIC (Cobimetinib) in People With Heavily Pre-Treated Locally Advanced or Metastatic Colorectal Cancer [businesswire.com]
vTv Therapeutics Announces Company will Pre-specify New Subgroup with the FDA and Report Phase 3 Part B Results in June | Business Wire [businesswire.com]
Puma Biotechnology Reports First Quarter 2018 Financial Results | Business Wire [businesswire.com]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018 [globenewswire.com]
PDL BioPharma Announces First Quarter 2018 Financial Results [prnewswire.com]
Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2018 | Business Wire [businesswire.com]
Ligand Reports First Quarter 2018 Financial Results | Business Wire [businesswire.com]
Quorum Health Corporation Announces First Quarter 2018 Financial and Operating Results | EON: Enhanced Online News [businesswire.com]
EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results [globenewswire.com]
Exelixis to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 [businesswire.com]
Exelixis to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 | Business Wire [businesswire.com]
Adverum Biotechnologies Announces Leadership Changes [globenewswire.com]
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018 [globenewswire.com]
Quorum Health Corporation Announces First Quarter 2018 Earnings Release & Conference Call Schedule | Business Wire [businesswire.com]
Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer | Business Wire [businesswire.com]
Exelixis Announces First Quarter 2018 Financial Results and Provides Corporate Update | Business Wire [businesswire.com]
Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer [businesswire.com]
Exelixis Announces First Quarter 2018 Financial Results and Provides Corporate Update [businesswire.com]
Free Research Reports on These Biotech Stocks -- Exelixis, INSYS Therapeutics, Intellia [prnewswire.com]
PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018 [prnewswire.com]
Free Research Reports on These Biotech Stocks -- Exelixis, INSYS Therapeutics, Intellia Therapeutics, and Intercept Pharma [prnewswire.com]
CalciMedica Names Two Senior Executives to its Board of Directors [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
